Study of micro-invasive glaucoma surgery options
Part of Eyes & vision clinical trials.
This trial studies outcomes after certain minimally invasive glaucoma surgeries, including the Preserflo microshunt. It may help improve how safely and effectively glaucoma surgery is done, and how patients are followed afterward.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older when you sign the consent form (no maximum age).
- You are planning to get a Preserflo microshunt, trabeculectomy, or another minimally invasive glaucoma surgery.
- You can reasonably cooperate during eye tests and study visits.
- You are willing to take part and can understand and sign informed consent.
- You do NOT have glaucoma caused by bleeding, injury/trauma, inflammation in the eye (uveitis-related), or high pressure from increased fluid pressure in the veins around the eye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a tiny implant called Preserflo to treat glaucoma (high eye pressure) that hasn't been controlled with eyedrops. The surgery aims to lower pressure safely while avoiding complications like pressure that drops too low.
This trial tests a tiny implant called MINIject S+ to lower eye pressure in people with open angle glaucoma that isn't well controlled with eye drops. It may be done alone or with cataract surgery.
This trial compares three types of tissue grafts (sclera, pericardium, and cornea) used during certain glaucoma surgeries. It aims to find which graft works best to help control eye pressure.
This trial tests two small drainage devices (PreserFlo and XEN stents) for glaucoma, sometimes with an amniotic membrane. The goal is to see which approach is safer and more effective at lowering eye pressure.
This trial is checking how well a combined eye surgery (Hydrus microstent plus canaloplasty plus cataract surgery) works over 3 years. It looks at long-term safety and effect on eye pressure. It's for people with open-angle glaucoma who already had that specific combination of procedures.
This study compares a glaucoma drainage device approach to see which one better prevents loss of corneal cells after surgery. You may benefit by receiving close monitoring around the time of glaucoma surgery and helping doctors improve surgical choices.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.